Showing 6,049 results

Filters Content type: News, Editors' picks, About HIV Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

New & experimental HIV treatments

ViiV Announces Expanded Access to Once-a-Day Integrase Inhibitor ... But Activists Are Concerned About Its Potential Misuse

Editor's pick
The Body
9 March 2012
The search for a cure

Drug brings HIV out of hiding

Editor's pick
Nature
9 March 2012
New & experimental HIV treatments

Novel integrase inhibitor dolutegravir still potent at 96 weeks

News
9 March 2012
HIV treatment for children & young people

Controversy regarding strategic treatment interruptions in young children who start ART during infancy

News
9 March 2012
Side effects

New Treatment Presented for Chronic Diarrhea in HIV/AIDS Patients

Editor's pick
MarketWatch (press release)
8 March 2012
Health services & systems

US: HIV Patients Not Staying In Care

Editor's pick
HIV / AIDS News From Medical News Today
8 March 2012
TB treatment

High dose of new HIV drug might improve outcomes for HIV/TB co-infected

Editor's pick
Science Speaks
8 March 2012
New & experimental HIV treatments

Tenofovir pro-drug GS-7340 shows good safety and efficacy in short study

News
8 March 2012
Bad science & bogus treatments

Uganda: Government and doctors insist circumcision reduces HIV spread

Editor's pick
Daily Monitor
8 March 2012
Health monitoring in resource-limited settings

When does viral load testing add value in sub-Saharan Africa?

News
8 March 2012
Global health initiatives

PEPFAR funding linked to lower death rate from all causes in Africa

News
8 March 2012
Weight gain & lipodystrophy

Lipoatrophy common in children receiving d4T in South Africa

News
7 March 2012
New & experimental HIV treatments

Gilead's Quad Single Tablet Regimen For HIV Non-Inferior To Atripla In Study

Editor's pick
NASDAQ
7 March 2012
Malaria

Lopinavir/ritonavir cuts malaria risk in children with HIV

News
7 March 2012
Treatment guidelines

Review questions efficacy of two WHO first-line TDF regimens

Editor's pick
International AIDS Society
7 March 2012
New & experimental HIV treatments

ViiV's Dolutegravir Continues to Show Well After 96 Weeks, Versus Sustiva, for First-Time Treatment

Editor's pick
AIDSMeds
7 March 2012
Injectable & long-acting PrEP

Once-a-month HIV drug maintains good levels for prevention; few side-effects so far

News
7 March 2012
PrEP science

Four doses of PrEP a week may be enough to protect

News
6 March 2012
PrEP science

A tale of two trials: how adherence is everything in PrEP

News
6 March 2012
Religion & faith

Ethiopians Trade Holy Water for AIDS Drugs

Editor's pick
Wall Street Journal
6 March 2012
Adherence

Adherence to bipolar medications may also promote adherence to antiretroviral therapy

Editor's pick
Agency for Healthcare Research and Quality
6 March 2012
Adherence

Guidelines for Improving Entry Into and Retention in Care and Antiretroviral Adherence for Persons With HIV

Editor's pick
Annals of Internal Medicine
5 March 2012
Adherence

IAPAC Guidelines Offer Recommendations to Optimize Entry into and Retention in HIV Care, and Treatment Adherence

Editor's pick
International Association of Physicians in AIDS Care
5 March 2012
New & experimental HIV treatments

Early Access Program for Integrase Inhibitor Dolutegravir Launched

Editor's pick
AIDSMeds
5 March 2012